Tscan Therapeutics
Price & Volume
Stats
See more52W Range | $1.99-$9.69 |
Market Cap | $122.6M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $9.3M |
Revenue Growth (YoY) | -73% |
Gross Profit (12 Mos) | -$91M |
Diluted EPS | -$0.95 |
News
See moreYahoo Finance • 7 days ago
TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
Yahoo Finance • last year
TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years
Yahoo Finance • last year
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
About
CEO | Dr. Gavin MacBeath Ph.D. |
CFO | Mr. Jason A. Amello CPA |
Address | 830 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 188 |
